Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 SGD | +7.69% | 0.00% | +18.64% |
12/04 | Singapore Shares Fall at Market Close; Biolidics Up 9% | MT |
12/04 | Trek 2000 Reports Variances in 2023 Statements | MT |
Sales 2022 | 16.62M 22.64M 1.39B | Sales 2023 | 16.76M 22.84M 1.4B | Capitalization | 14M 19.08M 1.17B |
---|---|---|---|---|---|
Net income 2022 | -13M -17.71M -1.08B | Net income 2023 | 2M 2.72M 167M | EV / Sales 2022 | -0.14 x |
Net cash position 2022 | 20.07M 27.35M 1.67B | Net cash position 2023 | 28.83M 39.28M 2.4B | EV / Sales 2023 | -0.88 x |
P/E ratio 2022 |
-1.34
x | P/E ratio 2023 |
5.21
x | Employees | 45 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.89% |
1 day | +7.69% | ||
1 month | +7.69% | ||
6 months | +9.38% | ||
Current year | +18.64% |
Managers | Title | Age | Since |
---|---|---|---|
Sheok Yeow Yeo
DFI | Director of Finance/CFO | 61 | 11/18/11 |
Joon Tan
CHM | Chairman | 36 | 24/18/24 |
Wei Xin Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joon Tan
CHM | Chairman | 36 | 24/18/24 |
Mun Kwong Kuan
PRN | Corporate Officer/Principal | 58 | 01/99/01 |
Swee Heng Kwek
BRD | Director/Board Member | 63 | 24/18/24 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.07 | +7.69% | 10,000 |
25/24/25 | 0.065 | -2.99% | 30,000 |
23/24/23 | 0.067 | -4.29% | 42,500 |
Delayed Quote Singapore S.E., April 26, 2024 at 12:29 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+18.64% | 16.08M | |
+36.26% | 23.3B | |
+14.94% | 20.91B | |
+48.49% | 17.2B | |
+14.15% | 2.44B | |
+12.20% | 785M | |
-8.17% | 776M | |
-25.57% | 720M | |
-7.29% | 439M | |
-32.45% | 324M |
- Stock Market
- Equities
- 5AB Stock